“…Phototherapeutic nanodrugs can be passively targeted to the nucleus by changing surface properties and size because of the highly physicochemical flexibility of nanomaterials ( Jiang et al, 2020 ; Xu et al, 2020 ). More importantly, active targeting of the nucleus can also be achieved by modifying nucleus-targeting groups such as cell-penetrating peptides [e.g., transactivator of transcription (TAT)] ( Su et al, 2020 ; Tietz et al, 2022 ), the specific nuclear localization signal/sequence (NLS) peptide ( Zelmer et al, 2020 ; Drescher et al, 2021 ), and DNA aptamers ( Dong et al, 2018 ; Yang et al, 2018 ; Zeng et al, 2020 ) on phototherapeutic nanodrugs. Apart from this, ROS generated by phototherapeutic nanodrugs can also damage the membrane structure to increase permeability ( Chen et al, 2021 ; Su et al, 2021 ; Chen et al, 2022 ).…”